All lobbying filings

Todd Strategy Group

Todd Strategy Group filed a Q3 report for Gilead Sciences, Inc. on October 19, 2026, reporting $80,000 in lobbying income.

Lobbying for Gilead Sciences, Inc. · American biotechnology company that researches, develops and commercializes drugs.

As filed: TODD STRATEGY GROUP for GILEAD SCIENCES, INC.

All filings by Todd Strategy Group · Everything Gilead Sciences, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 5

PAUL EDATTEL

Previously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD

Previously held: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
ERIC BERGREN

Previously held: Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
KATHERINE FLEMING COTTON

Previously held: Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
NICOLAS MAGALLANES

Previously held: Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Domestic and global drug pricing proposals. International trade and protection of intellectual property. Global supply chain issues. Proposals to expand access to HIV treatment and prevention therapies. Coverage and reimbursement policy for Hepatitis C, HIV and cancer. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. 340B program reforms and changes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.